Roche had a nose for success when the pharma giant ended the CHF500m deal with Polyphor in November 2015. Now,...
Up To Date
Latest News
Following the birth of genome-edited twins in China, the German Ethics Council has provided a complete ethical...
Immunotherapy and infection specialist BioNTech SE (Mainz, Germany) has acquired preclinical and clinial...
Epigenetic changes in immune cells may provide the trigger of multiple sclerosis. Researchers have now...
The round was led by BioGeneration Ventures and Wellington Partners, with Fund+, Perceptive Advisors and...
US scientists have found that the complex interactions between fat tissue and the immune system are mediated...
Share
